Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats

International Immunology

Volumn 23, Issue 7, 2011, Pages 443-451

  Cai, Yan ^a,b   Cao, Yong Xiao ^a   Lu, She Min ^a   Xu, Cang Bao ^c   Cardell, Lars Olaf ^d  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asthma; Cytokine; Inflammation; Receptor; Tumor necrosis factor alpha

Indexed keywords

BRADYKININ; ENDOTHELIN 1; IMMUNOGLOBULIN E; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLIXIMAB; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NITRIC OXIDE; OVALBUMIN; SARAFOTOXIN S6C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CONTROLLED STUDY; EOSINOPHIL; EX VIVO STUDY; HISTOLOGY; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG HOMOGENATE; LUNG LAVAGE; LUNG LOBE; LUNG PARENCHYMA; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 79960068925     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr032     Document Type: Article

References (37)

1. Pelaia, G., Renda, T., Gallelli, L. et al. 2008. Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respir. Med. 102:1173.
2. Malik, R., Priyadarsiny, P., Shirumalla, R., Soni, R., Ray, A. and Saini, K. 2008. Gene expression profile of ovalbumin-induced lung inflammation in a murine model of asthma. J. Investig. Allergol. Clin. Immunol. 18:106.
3. Leguillette, R. and Lauzon, A. M. 2008. Molecular mechanics of smooth muscle contractile proteins in airway hyperresponsiveness and asthma. Proc. Am. Thorac. Soc. 5:40.
4. Howarth, P. H., Babu, K. S., Arshad, H. S. et al. 2005. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60:1012.
5. Reuter, S., Heinz, A., Sieren, M. et al. 2008. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur. Respir. J. 31:773.
6. Brightling, C., Berry, M. and Amrani, Y. 2008. Targeting TNF-alpha: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol. 121:5.
7. Nakae, S., Ho, L. H., Yu, M. et al. 2007. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120:48.
8. Finotto, S., Ohno, I., Marshall, J. S. et al. 1994. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J. Immunol. 153:2278.
9. van Rijt, L. S. and Lambrecht, B. N. 2001. Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse. Microsc. Res. Tech. 53:256.
10. Jain, D., Keslacy, S., Tliba, O. et al. 2008. Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyperresponsiveness. Immunobiology 213:499.
11. Kharitonov, S. A., Wells, A. U., O'Connor, B. J. et al. 1995. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 151:1889.
12. Abe, M., Hayashi, Y., Murai, A. et al. 2006. Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule. Free Radic. Biol. Med. 40:1083.
13. Zhang, Y., Adner, M. and Cardell, L. O. 2007. IL-1beta-induced transcriptional up-regulation of bradykinin B1 and B2 receptors in murine airways. Am. J. Respir. Cell Mol. Biol. 36:697.
14. Adner, M., Rose, A. C., Zhang, Y. et al. 2002. An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction. Br. J. Pharmacol. 137:971.
15. Murai, A., Abe, M., Hayashi, Y., Sakata, N., Katsuragi, T. and Tanaka, K. 2005. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone. J. Pharmacol. Exp. Ther. 312:432.
16. Kurucz, I., Toth, S., Nemeth, K. et al. 2003. Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166). J. Pharmacol. Exp. Ther. 307:83.
17. Zhang, Y., Adner, M. and Cardell, L. O. 2004. Interleukin-1beta attenuates endothelin B receptor-mediated airway contractions in a murine in vitro model of asthma: roles of endothelin converting enzyme and mitogen-activated protein kinase pathways. Clin. Exp. Allergy. 34:1480.
18. Hashimoto, K., Peebles, R. S., Jr., Sheller, J. R. et al. 2002. Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor. Thorax 57:524.
19. Kropf, P., Fuentes, J. M., Fahnrich, E. et al. 2005. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 19:1000.
20. Doumas, B. T., Bayse, D. D., Carter, R. J., Peters, T., Jr. and Schaffer, R. 1981. A candidate reference method for determination of total protein in serum. I. Development and validation. Clin. Chem. 27:1642.
21. Warbrick, E. V., Dearman, R. J. and Kimber, I. 2002. Induced changes in total serum IgE concentration in the Brown Norway rat: potential for identification of chemical respiratory allergens. J. Appl. Toxicol. 22:1.
22. Wegmann, M., Fehrenbach, H., Fehrenbach, A. et al. 2005. Involvement of distal airways in a chronic model of experimental asthma. Clin. Exp. Allergy. 35:1263.
23. Ameredes, B. T., Otterbein, L. E., Kohut, L. K., Gligonic, A. L., Calhoun, W. J. and Choi, A. M. 2003. Low-dose carbon monoxide reduces airway hyperresponsiveness in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 285:L1270.
24. Foresi, A., Bertorelli, G., Pesci, A., Chetta, A. and Olivieri, D. 1990. Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission. Chest 98:528.
25. Laprise, C., Laviolette, M., Boutet, M. and Boulet, L. P. 1999. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur. Respir. J. 14:63.
26. Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M. and Vignola, A. M. 2000. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161:1720.
27. Wajant, H., Pfizenmaier, K. and Scheurich, P. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10:45.
28. Cazzola, M. and Polosa, R. 2006. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 6:43.
29. Russo, C. and Polosa, R. 2005. TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin. Sci. (Lond.) 109:135.
30. Erin, E. M., Leaker, B. R., Nicholson, G. C. et al. 2006. The effects of a monoclonal antibody directed against tumor necrosis factoralpha in asthma. Am. J. Respir. Crit. Care Med. 174:753.
31. Wenzel, S. E., Barnes, P. J., Bleecker, E. R. et al. 2009. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am. J. Respir. Crit. Care Med. 179:549.
32. Hutchison, S., Choo-Kang, B. S., Bundick, R. V. et al. 2008. Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation. Clin. Exp. Immunol. 151:114.
33. Hua, X., Chason, K. D., Fredholm, B. B., Deshpande, D. A., Penn, R. B. and Tilley, S. L. 2008. Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells. J. Allergy Clin. Immunol. 122:107.
34. Degano, B., Mourlanette, P., Valmary, S., Pontier, S., Prevost, M. C. and Escamilla, R. 2003. Differential effects of low and high-dose estradiol on airway reactivity in ovariectomized rats. Respir. Physiol. Neurobiol. 138:265.
35. Birrell, M. A., De Alba, J., Catley, M. C. et al. 2008. Liver X receptor agonists increase airway reactivity in a model of asthma via increasing airway smooth muscle growth. J. Immunol. 181:4265.
36. Mafra de Lima, F., Costa, M. S., Albertini, R., Silva, J. A., Jr. and Aimbire, F. 2009. Low level laser therapy (LLLT): attenuation of cholinergic hyperreactivity, beta(2)-adrenergic hyporesponsiveness and TNF-alpha mRNA expression in rat bronchi segments in E. coli lipopolysaccharide-induced airway inflammation by a NF-kappaB dependent mechanism. Lasers Surg. Med. 41:68.
37. Zhang, Y., Adner, M. and Cardell, L. O. 2004. Up-regulation of bradykinin receptors in a murine in-vitro model of chronic airway inflammation. Eur. J. Pharmacol. 489:117.